GH 1000 (1 Bottle System)
Product Code: 0150R
Retail Price: $49.95


GH 1000 The Professional Athlete's Strengh Training System Includes 30 day Supply of GH 1000 Formula and Professional Athlete's Strength Training Manual! The X-TREME GH 1000 is a unique combination of Isoflavones, Herbs, Sterols and B Vitamins designed to promote mineral / nitrogen retention, free or active testosterone levels, and regulate estrogen conversion. 5-Methyl 7-Methoxyisoflavone is an anabolic isoflavone that has been shown in early animal feed patents to increase mineral and nitrogen retention. 1 The Avena Sativa may have the ability to promote natural testosterone but more importantly may be able to promote free or active testosterone. 2 The promotion of free testosterone can cause a supercharging of testosterone's anabolic properties resulting in a much better overall effect. The ginger attempts to lower gastric acidity thus allowing for greater absorption of the ingredients. 3 The Diindolylmethane, Beta sitosterol, and Quercetin may have the ability to regulate estrogen conversion. 4, 5 Diindolylmethane is the new estrogen regulator, which is the active metabolite of Idole-3-carbinol. X-TREME GH 1000 is an ideal supplement for any bodybuilder attempting to promote muscle recovery and fat free mass. *

1. Feuer, L Et al. U.S. Patent#3,949,085 1976. "Anabolic-weight gain promoting compositions containing isoflavone derivatives and method using same" April: p.12. 2. Atal, CK. Et al. 1981. Scientific evidence on the role of Ayurvedic herbals on bioavailability of drugs J Ethnopharmacol. Sept; 4(2): p.229-232. 3. Fukushima, M. Et al. 1976. Extraction and purification of a substance with luteinizing hormone releasing activity from the leaves of Avena Sativa Tohoku J Exp Med. Jun; 119(2): 115-122. 4. Stresser, DM. Et al. 1995. J Biochem Toxicol. Aug: 10(4); p.191-201. 5. Sousa, RL., Marletta, MA. 1985. The inhibition of cytochrome P-450 activity in rat liver microsomes by the naturally occurring flavanoid, quercetin Arch Biochem Biophys. Jul; 240(1): p345-357.